The press writes itself, one of us should write it. "group of patients who failed treatment after developing metastatic disease survived more than 36 months after receiving leronlimab, are alive today, and currently identify as having no evidence of ongoing disease." Something about blocking metastasis, buying time, working in combination with current therapies etc. Maybe ohm20 can word a succinct and yet scientific version.

I don't think we have to worry like last year about the FDA, they are scrambling to keep their jobs. The only reason to keep quiet would be a current deal.